FDA approves for Winlevi (clascoterone cream 1%) for treatment of acne vulgaris in people aged 12 and older

Exact mechanism of action is unknown, but lab studies suggest clascoterone, competes with androgens, specifically DHT, for binding to androgen receptors within= sebaceous gland and hair follicles, limiting effects of these hormones on increasing sebum production and inflammation.

Biospace Inc.